Sushi K Srivastava

Title: Sushi K Srivastava: Innovator in Pharmaceutical Chemistry

Introduction

Sushi K Srivastava is a notable inventor based in Dayton, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for the production of important medicinal compounds. Her work has implications for the treatment of migraines, showcasing her innovative approach to drug development.

Latest Patents

Sushi K Srivastava holds a patent for a process aimed at large-scale production of indolyl alkyl pyrimidinyl. This patent describes an improved, novel convergent process suitable for the preparation of the antimigraine agent 4-(5-methoxy-4-pyrimidinyl)-1-[3-[5-[[(methylamino)sulfonyl]methyl]-1H-indol-3-yl]propyl]piperazine (BMS 180048) and its close analogs. The process enhances efficiencies in handling, purification, and product yield, and it involves a novel heteroannulation reaction that provides the indole ring moiety and propylpiperazinyl-pyrimidine backbone in a single step. She has 1 patent to her name.

Career Highlights

Sushi K Srivastava has had a distinguished career at Bristol-Myers Squibb Company, where she has been instrumental in advancing pharmaceutical research and development. Her innovative methodologies have contributed to the efficiency and effectiveness of drug production processes.

Collaborations

Throughout her career, Sushi has collaborated with esteemed colleagues, including Michael J Humora and Sandeep P Modi. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Sushi K Srivastava exemplifies the spirit of innovation in pharmaceutical chemistry. Her contributions to the development of efficient drug production processes highlight her role as a key inventor in the industry.